XBiotech Inc.
XBIT
$2.69
-$0.26-8.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.71M | 4.57M | 4.77M | 4.78M | 4.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.47M | 42.31M | 42.93M | 41.22M | 37.51M |
| Operating Income | -42.47M | -42.31M | -42.93M | -41.22M | -37.51M |
| Income Before Tax | -38.56M | -32.75M | -34.80M | -30.44M | -24.31M |
| Income Tax Expenses | -32.00K | -90.00K | 209.00K | 305.00K | 243.00K |
| Earnings from Continuing Operations | -38.53 | -32.66 | -35.01 | -30.74 | -24.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.53M | -32.66M | -35.01M | -30.74M | -24.56M |
| EBIT | -42.47M | -42.31M | -42.93M | -41.22M | -37.51M |
| EBITDA | -40.73M | -40.57M | -41.19M | -39.49M | -35.77M |
| EPS Basic | -1.27 | -1.07 | -1.15 | -1.01 | -0.81 |
| Normalized Basic EPS | -0.79 | -0.67 | -0.71 | -0.62 | -0.50 |
| EPS Diluted | -1.27 | -1.08 | -1.16 | -1.02 | -0.81 |
| Normalized Diluted EPS | -0.79 | -0.67 | -0.71 | -0.62 | -0.50 |
| Average Basic Shares Outstanding | 121.84M | 121.82M | 121.78M | 121.76M | 121.76M |
| Average Diluted Shares Outstanding | 121.84M | 121.82M | 121.78M | 121.76M | 121.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
